Investor conferences are a widely popular means for public companies to place themselves directly in front of willing and financially able investors looking for new investment options. With a particular focused on life sciences companies, the Redefining Early Stage Investments Conference (RESI) is coming up in Boston on September 16. RESI conference planners say the Boston event is on track to be RESI’s biggest event thus far, with an expected 600 attendees.
RESI is an ongoing conference series that connects early stage life sciences companies with attending investors, providing opportunities to create relationships that lead to funding. RESI Boston will bring together 200 eager and early stage corporate venture investors, 300 fundraising executives, and 100 service providers for a one day international partnering meeting that gives early stage life science companies the chance to book target meetings with relevant investors.
RESI creates meetings based on a common fit, which promotes compelling conversations, facilitating the development of qualified investor relationships. The RESI Partnering Forum allows fundraising executives to identify and book up to 16 meetings with life science investors who fit their company’s technology sector and stage of development. Presenting companies benefit from a receptive audience ready to hear each company’s story and business model.
Panels, workshops and one-on-one meetings throughout the course of the day create a fast-paced yet efficient atmosphere of productive dialogue, networking, presentations and close investment rounds designed to benefit the showcasing companies as well as investors in attendance.
Boston RESI follows highly successful events in San Francisco and Houston, and features a lineup of sponsors including Johnson & Johnson Innovation JLABS, Charles River Laboratories, McDermott Will & Emory and Wuxi App Tec.
For more information, visit www.resiconference.com
